Hideo Shimizu, Hirohiko Hohjoh. FMRP, FXR1 protein and Dlg4 mRNA, which are associated with fragile X syndrome, are involved in the ubiquitin-proteasome system. Scientific Reports. 2023. 13. 1
Kaoru Sato, Kanako Takahashi, Yukari Shigemoto-Mogami, Hideo Shimizu, Yuji Ikegaya, Ryuta Koyama, Toshimitsu Hiragi, Norimasa Miyamoto, Tomoaki Shirao, Yuko Sekino. iNCENS (iPSC non-clinical experiments for nervous system): A project to establish the CNS safety pharmacological evaluation to predict risks of cognitive impairment and epilepsy by in vitro use of human induced pluripotent stem cell-derived neurons. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS. 2016. 81. 386-386
Tomoaki Shirao, Yuta Ishizuka, Hideo Shimizu, Yuko Sekino. Search for the anti-amyloid beta drugs using primary neuronal cultures with drebrin cluster density as a marker of synaptic function. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS. 2015. 75. 171-171
Y. Ishizuka, H. Shimizu, T. Shirao. Histone deacetylase mediates drebrin loss from dendritic spines induced by amyloid beta oligomers. JOURNAL OF NEUROCHEMISTRY. 2015. 134. 273-274
Effects of histone deacetyltransferase inhibitor and allopregnanolone on neuron and synapses. -New analyzing system of neuronal and synaptic function using drebrin as a functional marker-.
(The 2013 International Conference on Brain and Health Informatics 2013)